Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-18
2006-07-18
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S338000, C546S256000, C546S268100, C546S282400
Reexamination Certificate
active
07078417
ABSTRACT:
This application relates to pyridine derivatives having the general structurein which the several variables are as defined in the specification and claims, and to a process for preparing these compounds, a pharmacutical composition containing such compounds, and a method for using these materials for treatment of stable and unstable angina pectoris and atrial fibrillation.
REFERENCES:
patent: 2003/0232860 (2003-12-01), Harada et al.
patent: 2386147 (2001-04-01), None
patent: 0285267 (1988-05-01), None
patent: 0285267 (1988-10-01), None
patent: 0908458 (1999-04-01), None
patent: 9412493 (1994-06-01), None
patent: 9412493 (1994-09-01), None
patent: 9916766 (1999-04-01), None
patent: 9916766 (1999-08-01), None
patent: 0125210 (2001-04-01), None
patent: 0162233 (2001-08-01), None
patent: 0125210 (2001-12-01), None
patent: 0206237 (2002-01-01), None
Kandeel et al., The use of Activated Double Bond Systems in Hetercocyclic Synthesis, Het.Comm., vol. 3, pp. 371-380 (1997).
Olah, M.E. et al., “Cloning expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.” J. Biol. Chem. 267 (1992) pp. 10764-10770.
Klotz, K.N. et al., “Comparative pharmacalogy of human adenosine receptor subtypes—characterization of stably transfected receptors in CHO Cells.” Naunyn Schmiedebergs Arch. Pharmacol. 357 (1998) 1-9.
Poulsen, S.A. et al., “Adeonosine Receptors: New Opportunities for Future Drugs”. Bioorganic and Medicinal Chemistry, 6 (1998) 619-641.
Broadley, K.J., “Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases.” Exp. Opin. Ther. Patents, 10 (2000) 1669-1692.
E. M. Kandeel, I. A. El-Ghamry, and A. H. Abd-El-Rahman, “The Use of Activated Double Bond Systems in Hetrocyclic Syntheses”, Heterocyclic Comm., 3(4): 371-380 (1997).
Dembowsky Klaus
Diedrichs Nicole
Hübsch Walter
Krahn Thomas
Krämer Thomas
Bayer Aktiengesellschaft
Solola Taofiq
LandOfFree
Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3531746